Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ...

With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...

(HealthDay)—A smartphone-operated one-lead electrocardiography (1L-ECG) device with an integral algorithm can diagnose atrial fibrillation (AF) and atrial flutter (AFL), according to a study published ...

Adults using medical cannabis for chronic pain, especially those with cancer or cardiometabolic disease, have a slightly elevated risk of developing arrhythmia, mainly atrial fibrillation/flutter, a ...

Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced it has received FDA 510 (k) clearance for its next-generation vMap ® technology. The clearance ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...